AzTrials
AzTrials

General AnesthesiaNCT07074730

General Anesthesia Versus Spinal Anesthesia With Local Anesthetic Infiltration for Buccal Mucosal Graft in Urethroplasty

A study testing Spinal anesthesia and General anesthesia in people with General Anesthesia and Spinal Anesthesia, run by Tanta University at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to compare general anesthesia and spinal anesthesia with local anesthetic infiltration for buccal mucosal graft (BMG) in urethroplasty. Read more about this study

Who is it for?
Ages 21 years and older, men only
What is being tested?
Spinal anesthesia and General anesthesia
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteEgypt
Study dates
19 Jul 2025to 1 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Male patient age ≥ 21 years.
  • American Society of Anesthesiologists (ASA) classification I-II.
  • Patient scheduled for urethroplasty.

Who cannot join

  • Patients who are taking analgesics for chronic illness or have a history of substance abuse.
  • Patients who are unable to describe their postoperative pain (e.g., neuropsychiatric disorder).
  • Patients with known local anesthetics and opioid allergy.
  • Patients with infection at the site of the needle puncture.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Aya Allah H Elbahy, Master contact

00201098959739

3ed2318@gmail.com

Egypt1 site, 1 recruiting
  • Tanta University

    Tanta, El-Gharbia, 31527

    Aya Allah H Elbahy, Master, 00201098959739, 3ed2318@gmail.com

    Osama M Shalaby, MD

    Recruiting

Other trials in Egypt

About this study

Official title: General Anesthesia Versus Spinal Anesthesia With Local Anesthetic Infiltration for Buccal Mucosal Graft in Urethroplasty: A Randomized Controlled Trial

This study aims to compare general anesthesia and spinal anesthesia with local anesthetic infiltration for buccal mucosal graft (BMG) in urethroplasty.

Read the detailed description

Urethroplasty is a surgical procedure aimed at reconstructing the urethra and is considered the standard treatment for bulbar urethral strictures, with different types of tissues used as either grafts or flaps, affecting approximately 300 per 100,000 males.

Postoperative pain following urethroplasty with buccal mucosal graft (BMG) is primarily related to the oral graft harvest site.

General Anesthesia provides a state of complete unconsciousness, ensuring that patients are free from pain and awareness during the surgery. It can be beneficial in complex cases or when extended manipulation is required, allowing for muscle relaxation and controlled ventilation.

On the other hand, spinal anesthesia involves the injection of anesthesia into the cerebrospinal fluid, resulting in targeted numbness in the lower body. This technique can be advantageous for its fast, simple, cost-effective method, rapid onset, lower risk of systemic complications, and preservation of airway reflexes.

Being tested
Spinal anesthesia, General anesthesia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Spinal anesthesiaOther

    Patients will receive spinal anesthesia with local anesthetic infiltration.

  • General anesthesiaOther

    Patients will receive general anesthesia.

Study groups in NCT07074730
Study groupRoleWhat they receive
Group SExperimentalSpinal anesthesia with local anesthetic infiltration.
Receives: Other: Spinal anesthesia
Group GActive comparatorGeneral anesthesia.
Receives: Other: General anesthesia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Degree of pain

    Each patient will be instructed about postoperative pain assessment with the Numerical rating Scale (NRS). NRS (0 represents "no pain"; (1-3) mild pain; (4-6) moderate pain; (7-10) severe pain. NRS will be assessed at 0, 4, 8, 12, 18 and 24h postoperatively.

    Measured: 24 hours postoperatively

Secondary outcomes (5)
  1. Postoperative morphine consumption

    Rescue analgesia of morphine will be given as 3 mg bolus if the Numerical rating Scale (NRS)> 3 to be repeated after 30 min if pain persists until the NRS< 4.

    Measured: 24 hours postoperatively

  2. Operative time

    Operative time will be recorded from the induction of anesthesia to discharge to the post-anesthesia care unit (PACU).

    Measured: Till discharge to post-anesthesia care unit (Up to 2 hours)

  3. Length of hospital stay

    Length of hospital stay will be recorded from admission till the discharge from the hospital.

    Measured: Till discharge from hospital (Up to one week).

  4. Patient satisfaction

    • Degree of patient satisfaction will be assessed on a 5-point Likert scale patient satisfaction (1, extremely unsatisfied; 2, unsatisfied; 3, neutral; 4, satisfied; 5, extremely satisfied).

    Measured: 24 hours postoperatively

  5. Incidence of complications

    Incidence of complications such as urinary retention, nausea, headache, local anesthetic systemic toxicity (LAST), bradycardia, hypotension, nausea, vomiting, respiratory depression or any other complication will be recorded.

    Measured: 24 hours postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jul 2025
  2. Study start19 Jul 2025
  3. Primary completion1 Mar 2027 (estimated)
  4. Study completion1 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07074730
Sponsor's protocol ID
36265MD360/1/25
Status last verified
Jul 2025
First submitted
10 Jul 2025
Last updated
22 Jul 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Questions about this trial

What is this clinical trial studying?

A study testing Spinal anesthesia and General anesthesia in people with General Anesthesia and Spinal Anesthesia, run by Tanta University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 22 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Aya Allah H Elbahy, Master (00201098959739, 3ed2318@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Degree of pain (time frame: 24 hours postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in